250 likes | 406 Views
The. EPEC-O. TM. Education in Palliative and End-of-life Care - Oncology. Project. The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation.
E N D
The EPEC-O TM Education in Palliative and End-of-life Care - Oncology Project The EPEC-O Curriculum is produced by the EPECTM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation.
EPEC – Oncology Education in Palliative and End-of-life Care – Oncology Module 3q Symptoms – Skin
Skin wounds . . . • Acute vs. chronic; likely to heal or not • Chemotherapy agent extravasation • Radiation damage • Decubitus ulcers • Malignant wounds
. . . Skin wounds Associated with • Pain • Depression • Anxiety • Poorer interpersonal interactions
Key points • Pathophysiology • Assessment • Management
Skin symptoms • Organ system • Highly innervated • Visible • Psychological, social, and spiritual • Interdisciplinary care • Symptom control
Chemotherapyextravasation: pathophysiology • Acute wound • Products of inflammation • Redness • Swelling • Pain • Cell death • Necrosis, open wound
Radiation: pathophysiology • Radiation damage • Acute wound • Products of inflammation • Cell death
Decubitus ulcers: pathophysiology • Pathophysiology • Ischemia • Fat is protective
Malignant wounds: pathophysiology • Disrupted physiology • Products of inflammation • Neovascularization • Bleeding • Necrosis • Anaerobic and fungal infections
Assessment . . . • Acute versus chronic • By wound type
Chemotherapy extravasation: assessment • Type of chemotherapy • Vesicant, eg, doxorubicin • Irritant, eg, carmustine • Non-irritants, eg, fluorouracil • Extent • Volume of extravasation and time • Seconds, minutes, hours • Involved anatomy
Radiation: assessment • Radiation sensitizers • Topical agents • Drugs, including chemotherapy • Dose and fractionation schedule • Expected course
Decubitus ulcers • Assessment • Risk factors • Prevention • Skin protection – shear / tear / moisture • Pressure reduction and pressure relief
Decubitus ulcers: staging • Non-blanchable erythema • Partial-thickness skin loss • Full-thickness skin loss • Extensive necrosis exposing muscle or bone
Management • Acute versus chronic • By wound type
Necrotic wound: management • Debridement • Surgical • Enzymes and gels • Mechanical • Pain control • Cleansing
Chemotherapy extravasation: management • Contain damage • Stop infusion • Neutralize • Assess for surgical consultation • Watch and wait
Radiation: management • Promote healing • Avoid cytotoxic agents • Moist environment • Treat infection • Pain control
Decubitus ulcers: management • Goals: healing vs non-healing • Healing • Debridement • Dressings that promote healing • Non-healing • Pain control, comfort • Prevent worsening
Decubitus ulcers: dressing • Moist, interactive environment • Control infection • 6 types of dressing • Foams • Alginates • Hydrogels • Hydrocolloids • Thin films • Cotton gauze
Malignant wounds: management • Healing vs non-healing • Infections • Odors • Pain • Exudate • Bleeding
Odors • Topical and / or systemic antibiotics • Metronidazole • Silver sulfadiazine • Kitty litter • Activated charcoal • Vinegar • Burning candles
Summary Use comprehensive assessment and pathophysiology-based therapy to treat the cause and improve the cancer experience